KaloBios Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
KaloBios is a biotechnology research company focused on developing innovative antibody therapies for cancer. Its core objective is to improve patient outcomes through Humaneered® monoclonal antibodies that are tailored to enhance beneficial effects while reducing unwanted ones, with a pipeline centered on these customized antibodies. The company targets oncology and hematologic malignancies, pursuing clinical development ofKB004 (anti-EphA3) and KB003 (anti-GM-CSF) in various cancer indications, including myelofibrosis, myelodysplastic syndrome, and CMML, and employs patient-targeted approaches to identify individuals most likely to benefit from its treatments. Based in South San Francisco, California, KaloBios operates within the biotechnology research sector, pursuing a translational strategy that integrates antibody design with clinical evaluation to address unmet needs in cancer therapy.